These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37859414)

  • 1. Anti-
    Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
    Parasitology; 2023 Nov; 150(13):1226-1235. PubMed ID: 37859414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice.
    Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
    PLoS One; 2023; 18(7):e0288335. PubMed ID: 37418497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted Phenotypic Screening in
    Subramanian G; Belekar MA; Shukla A; Tong JX; Sinha A; Chu TTT; Kulkarni AS; Preiser PR; Reddy DS; Tan KSW; Shanmugam D; Chandramohanadas R
    mSphere; 2018; 3(1):. PubMed ID: 29359192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicines for Malaria Venture Pandemic Box In Vitro Screening Identifies Compounds Highly Active against the Tachyzoite Stage of
    Dos Santos M; Oliveira Costa AL; Vaz GHS; de Souza GCA; Vitor RWA; Martins-Duarte ÉS
    Trop Med Infect Dis; 2023 Nov; 8(12):. PubMed ID: 38133442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica.
    Boyom FF; Fokou PV; Tchokouaha LR; Spangenberg T; Mfopa AN; Kouipou RM; Mbouna CJ; Donfack VF; Zollo PH
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5848-54. PubMed ID: 25049259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of fungal natural products with potent inhibition in
    Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
    Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against
    Cajazeiro DC; Toledo PPM; de Sousa NF; Scotti MT; Reimão JQ
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015260
    [No Abstract]   [Full Text] [Related]  

  • 10. First Description of Marinoquinoline Derivatives' Activity against
    Diethelm LTH; Ramos ABDSB; de Lorena GB; Trajano BI; do Espírito Santo RD; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Correia CRD; Reimão JQ
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-tryptophan-titanium oxide nanoparticles showed selective anti-Toxoplasma gondii activity and improved host biocompatibility.
    Adeyemi OS; Ishii K; Kato K
    Biomed Pharmacother; 2023 Jun; 162():114597. PubMed ID: 36989712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity.
    Zhang LH; Jin LL; Liu F; Jin C; Jin CM; Wei ZY
    Exp Parasitol; 2020 Sep; 216():107935. PubMed ID: 32569599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro and in vivo biological evaluation of dihydroartemisinin derivatives with potential anti-Toxoplasma gondii agents.
    Deng H; Huang X; Jin C; Jin CM; Quan ZS
    Bioorg Chem; 2020 Jan; 94():103467. PubMed ID: 31791681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling and experimental validation identified a new therapeutic inhibitor of toxoplasmosis.
    Adeyemi OS; Johnson T; Maduakolam-Aniobi T; Kato K
    Comput Biol Med; 2024 Dec; 183():109236. PubMed ID: 39378576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
    Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
    Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against
    Ma Y; Cao X; Wang H; Song X; Hu D
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076987
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents.
    Zhang HB; Shen QK; Wang H; Jin C; Jin CM; Quan ZS
    Eur J Med Chem; 2018 Oct; 158():414-427. PubMed ID: 30237124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiprotozoal activity of auranofin on Trypanosoma cruzi, Leishmania tropica and Toxoplasma gondii: in vitro and ex vivo study.
    Yıldırım A; Özbilgin A; Yereli K
    Trans R Soc Trop Med Hyg; 2023 Oct; 117(10):733-740. PubMed ID: 37377375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies.
    Salin NH; Noordin R; Al-Najjar BO; Kamarulzaman EE; Yunus MH; Karim IZA; Nasim NNM; Zakaria II; Wahab HA
    PLoS One; 2020; 15(5):e0225232. PubMed ID: 32442170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.